Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SUN PHARM

  • FDA Approval
  • Sept. 25, 2024, 08:41 UTC
  • 35
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

TEYRO LABS

  • FDA Approval
  • Sept. 25, 2024, 08:41 UTC
  • 43
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

GLENMARK SPECLT

  • FDA Approval
  • Sept. 25, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve LINEZOLID

Comment Full text

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 25, 2024, 08:41 UTC
  • 42
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

BARR

  • FDA Approval
  • Sept. 25, 2024, 08:41 UTC
  • 37
  • 0 comments

FDA approve HYDROXYUREA

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Sept. 25, 2024, 08:40 UTC
  • 35
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Sept. 25, 2024, 08:40 UTC
  • 33
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Sept. 25, 2024, 08:40 UTC
  • 37
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Sept. 25, 2024, 08:40 UTC
  • 38
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Sept. 25, 2024, 08:40 UTC
  • 36
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text
  • Previous
  • 345
  • 346
  • 347
  • 348
  • 349
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137484)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin